New York, USA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LAG-3 Immunotherapies Market Set for Rapid Growth in the Coming 10 Years Across the 7MM as Next-Generation Therapies Advance | DelveInsight The LAG ...

LAG-3 drugs from arch-rivals Bristol-Myers Squibb and Merck & Co look set to become talking points at this year's ASCO conference after trial results showed their potential as next-generation ...

Shares in Immutep have leapt after the biotech reported phase 2b results showing that LAG-3 inhibitor eftilagimod alfa (efti) significantly boosted the efficacy of MSD’s Keytruda in patients ...

Most low-birth-weight toddlers are not on track to be ready to attend school, a new study says.Only one-third of babi ...

Full Year 2024 Results Key Financial Results Revenue: US$98.4m (up 9.2% from ...

This 3-rotor Mazda RX-7 sounds absolutely wild with its aggressive anti-lag system! 🔥💥 Watch as it spits flames, crackles, ...

In patients with advanced melanoma, nivolumab/relatlimab combination therapy shows a cutaneous irAEs prevalence of 21.5%, ...

Macy's shares dropped in premarket following a 4.3% decline in fourth-quarter sales. However, the company posted a positive ...

Trump is likely to announced a BTC reserve and positive outlook for altcoins at Friday's crypto summit. Despite Trump's ...

Sleep Number reported a mixed earnings release with better-than-expected earnings but lower revenue, indicating successful ...

Snapdragon 7 Gen 3 vs 7s Gen 3 showdown! See how these two chips stack up on benchmarks and explore key differences to find ...